|
1
|
Hirsch FR, Scagliotti GV, Mulshine JL,
Kwon R, Curran WJ Jr, Wu YL and Paz-Ares L: Lung cancer: Current
therapies and new targeted treatments. Lancet. 389:299–311. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tsim S, O'Dowd CA, Milroy R and Davidson
S: Staging of non-small cell lung cancer (NSCLC): A review. Respir
Med. 104:1767–1674. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Giovannetti E, Toffalorio F, De Pas T and
Peters GJ: Pharmacogenetics of conventional chemotherapy in
non-small-cell lung cancer: A changing landscape? Pharmacogenomics.
13:1073–1086. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu Y and He J: Molecular classification of
non-small-cell lung cancer: Diagnosis, individualized treatment,
and prognosis. Front Med. 7:157–171. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Minguet J, Smith KH and Bramlage P:
Targeted therapies for treatment of non-small cell lung
cancer-recent advances and future perspectives. Int J Cancer.
138:2549–2561. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rotow J and Bivona TG: Understanding and
targeting resistance mechanisms in NSCLC. Nat Rev Cancer.
17:637–658. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hallstrom TC and Nevins JR: Balancing the
decision of cell proliferation and cell fate. Cell Cycle.
8:532–535. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Choi AM, Ryter SW and Levine B: Autophagy
in human health and disease. N Engl J Med. 368:651–662. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu G, Pei F, Yang F, Li L, Amin AD, Liu
S, Buchan JR and Cho WC: Role of autophagy and apoptosis in
non-small-cell lung cancer. Int J Mol Sci. 18:3672017. View Article : Google Scholar
|
|
13
|
Perlikos F, Harrington KJ and Syrigos KN:
Key molecular mechanisms in lung cancer invasion and metastasis: A
comprehensive review. Crit Rev Oncol Hematol. 87:1–11. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P
and Wu M: CircRNA: Functions and properties of a novel potential
biomarker for cancer. Mol Cancer. 16:942017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Petkovic S and Müller S: RNA
circularization strategies in vivo and in vitro. Nucleic Acids Res.
43:2454–2465. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dong Y, He D, Peng Z, Peng W, Shi W, Wang
J, Li B, Zhang C and Duan C: Circular RNAs in cancer: An emerging
key player. J Hematol Oncol. 10:22017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y, Liu J, Ma J, Sun T, Zhou Q, Wang
W, Wang G, Wu P, Wang H, Jiang L, et al: Exosomal circRNAs:
Biogenesis, effect and application in human diseases. Mol Cancer.
18:1162019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li T, Shao Y, Fu L, Xie Y, Zhu L, Sun W,
Yu R, Xiao B and Guo J: Plasma circular RNA profiling of patients
with gastric cancer and their droplet digital RT-PCR detection. J
Mol Med (Berl). 96:85–96. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Geng Y, Jiang J and Wu C: Function and
clinical significance of circRNAs in solid tumors. J Hematol Oncol.
11:982018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang M and Xin Y: Circular RNAs: A new
frontier for cancer diagnosis and therapy. J Hematol Oncol.
11:212018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Z, Yang T and Xiao J: Circular RNAs:
Promising biomarkers for human diseases. EBioMedicine. 34:267–274.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Yang L and Chen LL: The biogenesis,
functions, and challenges of circular RNAs. Mol Cell. 71:428–442.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bezzi M, Guarnerio J and Pandolfi PP: A
circular twist on microRNA regulation. Cell Res. 27:1401–1402.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang H, Cai K, Wang J, Wang X, Cheng K,
Shi F, Jiang L, Zhang Y and Dou J: MiR-7, inhibited indirectly by
lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of
breast cancer stem cells by downregulating the STAT3 pathway. Stem
Cells. 32:2858–2868. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu S, Zhang P, Chen Z, Liu M, Li X and
Tang H: MicroRNA-7 downregulates XIAP expression to suppress cell
growth and promote apoptosis in cervical cancer cells. FEBS Lett.
587:2247–2253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kong D, Piao YS, Yamashita S, Oshima H,
Oguma K, Fushida S, Fujimura T, Minamoto T, Seno H, Yamada Y, et
al: Inflammation-induced repression of tumor suppressor miR-7 in
gastric tumor cells. Oncogene. 31:3949–3960. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fang Y, Xue JL, Shen Q, Chen J and Tian L:
MicroRNA-7 inhibits tumor growth and metastasis by targeting the
phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Hepatology. 55:1852–1862. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sang M, Meng L, Sang Y, Liu S, Ding P, Ju
Y, Liu F, Gu L, Lian Y, Li J, et al: Circular RNA ciRS-7
accelerates ESCC progression through acting as a miR-876-5p sponge
to enhance MAGE-A family expression. Cancer Lett. 426:37–46. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu C, Yao MD, Li CP, Shan K, Yang H, Wang
JJ, Liu B, Li XM, Yao J, Jiang Q and Yan B: Silencing of circular
RNA-ZNF609 ameliorates vascular endothelial dysfunction.
Theranostics. 7:2863–2877. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Conn SJ, Pillman KA, Toubia J, Conn VM,
Salmanidis M, Phillips CA, Roslan S, Schreiber AW, Gregory PA and
Goodall GJ: The RNA binding protein quaking regulates formation of
circRNAs. Cell. 160:1125–1134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Du WW, Yang W, Liu E, Yang Z, Dhaliwal P
and Yang BB: Foxo3 circular RNA retards cell cycle progression via
forming ternary complexes with p21 and CDK2. Nucleic Acids Res.
44:2846–2858. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Du WW, Fang L, Yang W, Wu N, Awan FM, Yang
Z and Yang BB: Induction of tumor apoptosis through a circular RNA
enhancing Foxo3 activity. Cell Death Differ. 24:357–370. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang Y and Wang Z: Efficient backsplicing
produces translatable circular mRNAs. RNA. 21:172–179. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen CY and Sarnow P: Initiation of
protein synthesis by the eukaryotic translational apparatus on
circular RNAs. Science. 268:415–417. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Perriman R and Ares M Jr: Circular mRNA
can direct translation of extremely long repeating-sequence
proteins in vivo. RNA. 4:1047–1054. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Abe N, Matsumoto K, Nishihara M, Nakano Y,
Shibata A, Maruyama H, Shuto S, Matsuda A, Yoshida M, Ito Y and Abe
H: Rolling circle translation of circular RNA in living human
cells. Sci Rep. 5:164352015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Legnini I, Di Timoteo G, Rossi F, Morlando
M, Briganti F, Sthandier O, Fatica A, Santini T, Andronache A, Wade
M, et al: Circ-ZNF609 is a circular RNA that can be translated and
functions in myogenesis. Mol Cell. 66:22–37.e9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang Y, Gao X, Zhang M, Yan S, Sun C, Xiao
F, Huang N, Yang X, Zhao K, Zhou H, et al: Novel role of FBXW7
circular RNA in repressing glioma tumorigenesis. J Natl Cancer
Inst. 110:304–315. 2018. View Article : Google Scholar
|
|
40
|
Zhang M, Huang N, Yang X, Luo J, Yan S,
Xiao F, Chen W, Gao X, Zhao K, Zhou H, et al: A novel protein
encoded by the circular form of the SHPRH gene suppresses glioma
tumorigenesis. Oncogene. 37:1805–1814. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Westholm JO, Miura P, Olson S, Shenker S,
Joseph B, Sanfilippo P, Celniker SE, Graveley BR and Lai EC:
Genome-wide analysis of drosophila circular RNAs reveals their
structural and sequence properties and age-dependent neural
accumulation. Cell Rep. 9:1966–1980. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Holdt LM, Stahringer A, Sass K, Pichler G,
Kulak NA, Wilfert W, Kohlmaier A, Herbst A, Northoff BH, Nicolaou
A, et al: Circular non-coding RNA ANRIL modulates ribosomal RNA
maturation and atherosclerosis in humans. Nat Commun. 7:124292016.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li Z, Huang C, Bao C, Chen L, Lin M, Wang
X, Zhong G, Yu B, Hu W, Dai L, et al: Exon-intron circular RNAs
regulate transcription in the nucleus. Nat Struct Mol Biol.
22:256–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Salzman J, Gawad C, Wang PL, Lacayo N and
Brown PO: Circular RNAs are the predominant transcript isoform from
hundreds of human genes in diverse cell types. PLoS One.
7:e307332012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang Y, Zhang XO, Chen T, Xiang JF, Yin
QF, Xing YH, Zhu S, Yang L and Chen LL: Circular intronic long
noncoding RNAs. Mol Cell. 51:792–806. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Harrison PM, Zheng D, Zhang Z, Carriero N
and Gerstein M: Transcribed processed pseudogenes in the human
genome: An intermediate form of expressed retrosequence lacking
protein-coding ability. Nucleic Acids Res. 33:2374–2383. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kalyana-Sundaram S, Kumar-Sinha C, Shankar
S, Robinson DR, Wu YM, Cao X, Asangani IA, Kothari V, Prensner JR,
Lonigro RJ, et al: Expressed pseudogenes in the transcriptional
landscape of human cancers. Cell. 149:1622–1634. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang Z, Harrison PM, Liu Y and Gerstein
M: Millions of years of evolution preserved: A comprehensive
catalog of the processed pseudogenes in the human genome. Genome
Res. 13:2541–2558. 2015. View Article : Google Scholar
|
|
49
|
Dong R, Zhang XO, Zhang Y, Ma XK, Chen LL
and Yang L: CircRNA-derived pseudogenes. Cell Res. 26:747–750.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J,
Chen D, Gu J, He X and Huang S: Circular RNA is enriched and stable
in exosomes: A promising biomarker for cancer diagnosis. Cell Res.
25:981–984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lei B, Tian Z, Fan W and Ni B: Circular
RNA: A novel biomarker and therapeutic target for human cancers.
Int J Med Sci. 16:292–301. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Li Z, Ruan Y, Zhang H, Shen Y, Li T and
Xiao B: Tumor-suppressive circular RNAs: Mechanisms underlying
their suppression of tumor occurrence and use as therapeutic
targets. Cancer Sci. 110:3630–3638. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Li Y, Ge YZ, Xu L and Jia R: Circular RNA
ITCH: A novel tumor suppressor in multiple cancers. Life Sci.
254:1171762020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Jiang MM, Mai ZT, Wan SZ, Chi YM, Zhang X,
Sun BH and Di QG: Microarray profiles reveal that circular RNA
hsa_circ_0007385 functions as an oncogene in non-small cell lung
cancer tumorigenesis. J Cancer Res Clin Oncol. 144:667–674. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Li C, Zhang L, Meng G, Wang Q, Lv X, Zhang
J and Li J: Circular RNAs: Pivotal molecular regulators and novel
diagnostic and prognostic biomarkers in non-small cell lung cancer.
J Cancer Res Clin Oncol. 145:2875–2889. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Mu Y, Xie F, Huang Y, Yang D, Xu G, Wang C
and Wu Q: Circular RNA expression profile in peripheral whole blood
of lung adenocarcinoma by high: Throughput sequencing. Medicine
(Baltimore). 98:e176012019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chen LL and Yang L: Regulation of circRNA
biogenesis. RNA Biol. 12:381–388. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhang S, Zeng X, Ding T, Guo L, Li Y, Ou S
and Yuan H: Microarray profile of circular RNAs identifies
hsa_circ_0014130 as a new circular RNA biomarker in non-small cell
lung cancer. Sci Rep. 8:28782018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chen L, Nan A, Zhang N, Jia Y, Li X, Ling
Y, Dai J, Zhang S, Yang Q, Yi Y and Jiang Y: Circular RNA 100146
functions as an oncogene through direct binding to miR-361-3p and
miR-615-5p in non-small cell lung cancer. Mol Cancer. 18:132019.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Qiu M, Xia W, Chen R, Wang S, Xu Y, Ma Z,
Xu W, Zhang E, Wang J, Fang T, et al: The circular RNA circPRKCI
promotes tumor growth in lung adenocarcinoma. Cancer Res.
78:2839–2851. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Hsiao KY, Lin YC, Gupta SK, Chang N, Yen
L, Sun HS and Tsai SJ: Noncoding effects of circular RNA CCDC66
promote colon cancer growth and metastasis. Cancer Res.
77:2339–2350. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Joseph NA, Chiou SH, Lung Z, Yang CL, Lin
TY, Chang HW, Sun HS, Gupta SK, Yen L, Wang SD, et al: The role of
HGF-MET pathway and CCDC66 cirRNA expression in EGFR resistance and
epithelial-to-mesenchymal transition of lung adenocarcinoma cells.
J Hematol Oncol. 11:742018. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Chen D, Ma W, Ke Z and Xie F: CircRNA
hsa_circ_100395 regulates miR-1228/TCF21 pathway to inhibit lung
cancer progression. Cell Cycle. 17:2080–2090. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Han J, Zhao G, Ma X, Dong Q, Zhang H, Wang
Y and Cui J: CircRNA circ-BANP-mediated miR-503/LARP1 signaling
contributes to lung cancer progression. Biochem Biophys Res Commun.
503:2429–2435. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Pack LR, Daigh LH and Meyer T: Putting the
brakes on the cell cycle: Mechanisms of cellular growth arrest.
Curr Opin Cell Biol. 60:106–113. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Juríková M, Danihel Ľ, Polák Š and Varga
I: Ki67, PCNA, and MCM proteins: Markers of proliferation in the
diagnosis of breast cancer. Acta Histochem. 118:544–552. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhao F, Han Y, Liu Z, Zhao Z, Li Z and Jia
K: circFADS2 regulates lung cancer cells proliferation and invasion
via acting as a sponge of miR-498. Biosci Rep. 38:BSR201805702018.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Zhang X, Yang D and Wei Y: Overexpressed
CDR1as functions as an oncogene to promote the tumor progression
via miR-7 in non-small-cell lung cancer. Onco Targets Ther.
11:3979–3987. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhu XF, Liu ZC, Xie BF, Li ZM, Feng GK,
Yang D and Zeng YX: EGFR tyrosine kinase inhibitor AG1478 inhibits
cell proliferation and arrests cell cycle in nasopharyngeal
carcinoma cells. Cancer Lett. 169:27–32. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Nakayama K, Rahman MT, Rahman M, Nakamura
K, Ishikawa M, Katagiri H, Sato E, Ishibashi T, Iida K, Ishikawa N
and Kyo S: CCNE1 amplification is associated with aggressive
potential in endometrioid endometrial carcinomas. Int J Oncol.
48:506–516. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Su C, Han Y, Zhang H, Li Y, Yi L, Wang X,
Zhou S, Yu D, Song X, Xiao N, et al: CiRS-7 targeting miR-7
modulates the progression of non-small cell lung cancer in a manner
dependent on NF-κB signalling. J Cell Mol Med. 22:3097–3107. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Zhu X, Wang X, Wei S, Chen Y, Chen Y, Fan
X, Han S and Wu G: hsa_circ_0013958: A circular RNA and potential
novel biomarker for lung adenocarcinoma. FEBS J. 284:2170–2182.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Donnellan R and Chetty R: Cyclin D1 and
human neoplasia. Mol Pathol. 51:1–7. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Chi Y, Luo Q, Song Y, Yang F, Wang Y, Jin
M and Zhang D: Circular RNA circPIP5K1A promotes non-small cell
lung cancer proliferation and metastasis through miR-600/HIF-1α
regulation. J Cell Biochem. 120:19019–19030. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Nan A, Chen L, Zhang N, Jia Y, Li X, Zhou
H, Ling Y, Wang Z, Yang C, Liu S and Jiang Y: Circular RNA
circNOL10 inhibits lung cancer development by promoting
SCLM1-mediated transcriptional regulation of the humanin
polypeptide family. Adv Sci (Weinh). 6:18006542018. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Qin M, Wei G and Sun X: Circ-UBR5: An
exonic circular RNA and novel small nuclear RNA involved in RNA
splicing. Biochem Biophys Res Commun. 503:1027–1034. 2019.
View Article : Google Scholar
|
|
77
|
Chen X, Mao R, Su W, Yang X, Geng Q, Guo
C, Wang Z, Wang J, Kresty LA, Beer DG, et al: Circular RNA
circHIPK3 modulates autophagy via MIR124-3p-STAT3-PRKAA/AMPKα
signaling in STK11 mutant lung cancer. Autophagy. 16:659–671. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
You L, Wang Z, Li H, Shou J, Jing Z, Xie
J, Sui X, Pan H and Han W: The role of STAT3 in autophagy.
Autophagy. 11:729–739. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Espinosa-Oliva AM, García-Revilla J,
Alonso-Bellido IM and Burguillos MA: Brainiac caspases: Beyond the
wall of apoptosis. Front Cell Neurosci. 13:5002019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Pistritto G, Trisciuoglio D, Ceci C,
Garufi A and D'Orazi G: Apoptosis as anticancer mechanism: Function
and dysfunction of its modulators and targeted therapeutic
strategies. Aging (Albany NY). 8:603–619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Wong RS: Apoptosis in cancer: From
pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
An J, Shi H, Zhang N and Song S: Elevation
of circular RNA circ_0003645 forecasts unfavorable prognosis and
facilitates cell progression via miR-1179/TMEM14A pathway in
non-small cell lung cancer. Biochem Biophys Res Commun.
511:921–925. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Gao P, Wang Z, Hu Z, Jiao X and Yao Y:
Circular RNA circ_0074027 indicates a poor prognosis for NSCLC
patients and modulates cell proliferation, apoptosis, and invasion
via miR-185-3p mediated BRD4/MADD activation. J Cell Biochem.
121:2632–2642. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Zeng Z, Zhou W, Duan L, Zhang J, Lu X, Jin
L and Yu Y: Circular RNA circ-VANGL1 as a competing endogenous RNA
contributes to bladder cancer progression by regulating
miR-605-3p/VANGL1 pathway. J Cell Physiol. 234:3887–3896. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Wang L, Ma H, Kong W, Liu B and Zhang X:
Up-regulated circular RNA VANGL1 contributes to progression of
non-small cell lung cancer through inhibition of miR-195 and
activation of Bcl-2. Biosci Rep. 39:BSR201824332019. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Li X, Zhang Z, Jiang H, Li Q, Wang R, Pan
H, Niu Y, Liu F, Gu H, Fan X and Gao J: Circular RNA circPVT1
promotes proliferation and invasion through sponging miR-125b and
activating E2F2 signaling in non-small cell lung cancer. Cell
Physiol Biochem. 51:2324–2340. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Kramer N, Walzl A, Unger C, Rosner M,
Krupitza G, Hengstschläger M and Dolznig H: In vitro cell migration
and invasion assays. Mutat Res. 752:10–24. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Goossens S, Vandamme N, Van Vlierberghe P
and Berx G: EMT transcription factors in cancer development
re-evaluated: Beyond EMT and MET. Biochim Biophys Acta Rev Cancer.
1868:584–591. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Diepenbruck M and Christofori G:
Epithelial-mesenchymal transition (EMT) and metastasis: Yes, no,
maybe? Curr Opin Cell Biol. 43:7–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Wang L, Zheng C, Wu X, Zhang Y, Yan S,
Ruan L and Dai H: Circ-SOX4 promotes non-small cell lung cancer
progression by activating the Wnt/beta-catenin pathway. Mol Oncol.
2020.
|
|
91
|
Gao N and Ye B: Circ-SOX4 drives the
tumorigenesis and development of lung adenocarcinoma via sponging
miR-1270 and modulating PLAGL2 to activate WNT signaling pathway.
Cancer Cell Int. 20:22020. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Wang L, Tong X, Zhou Z, Wang S, Lei Z,
Zhang T, Liu Z, Zeng Y, Li C, Zhao J, et al: Circular RNA
hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced
epithelial-mesenchymal transition and metastasis by controlling
TIF1γ in non-small cell lung cancer. Mol Cancer. 17:1402018.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Winer A, Adams S and Mignatti P: Matrix
metalloproteinase inhibitors in cancer therapy: Turning past
failures into future successes. Mol Cancer Ther. 17:1147–1155.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Wang L, Liang Y, Mao Q, Xia W, Chen B,
Shen H, Xu L, Jiang F and Dong G: Circular RNA circCRIM1 inhibits
invasion and metastasis in lung adenocarcinoma through the microRNA
(miR)-182/miR-93-leukemia inhibitory factor receptor pathway.
Cancer Sci. 110:2960–2972. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Shi JQ, Wang B, Cao XQ, Wang YX, Cheng X,
Jia CL, Wen T, Luo BJ and Liu ZD: Circular RNA_LARP4 inhibits the
progression of non-small-cell lung cancer by regulating the
expression of SMAD7. Eur Rev Med Pharmacol Sci. 24:1863–1869.
2020.PubMed/NCBI
|
|
96
|
Wan L, Zhang L, Fan K, Cheng ZX, Sun QC
and Wang JJ: Circular RNA-ITCH suppresses lung cancer proliferation
via inhibiting the Wnt/β-catenin pathway. Biomed Res Int.
2016:15794902016. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Zhitomirsky B and Assaraf YG: Lysosomes as
mediators of drug resistance in cancer. Drug Resist Updat.
24:23–33. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Fraipont F, Gazzeri S, Cho WC and Eymin B:
Circular RNAs and RNA splice variants as biomarkers for prognosis
and therapeutic response in the liquid biopsies of lung cancer
patients. Front Genet. 10:3902019. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Dong Y, Xu T, Zhong S, Wang B, Zhang H,
Wang X, Wang P, Li G and Yang S: Circ_0076305 regulates cisplatin
resistance of non-small cell lung cancer via positively modulating
STAT3 by sponging miR-296-5p. Life Sci. 239:1169842019. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Huang MS, Liu JY, Xia XB, Liu YZ, Li X,
Yin JY, Peng JB, Wu L, Zhang W, Zhou HH and Liu ZQ:
Hsa_circ_0001946 inhibits lung cancer progression and mediates
cisplatin sensitivity in non-small cell lung cancer via the
nucleotide excision repair signaling pathway. Front Oncol.
9:5082019. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Li X, Yang B, Ren H, Xiao T, Zhang L, Li
L, Li M, Wang X, Zhou H and Zhang W: Hsa_circ_0002483 inhibited the
progression and enhanced the Taxol sensitivity of non-small cell
lung cancer by targeting miR-182-5p. Cell Death Dis. 10:9532019.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Xiao G, Huang W, Zhan Y, Li J and Tong W:
CircRNA_103762 promotes multidrug resistance in NSCLC by targeting
DNA damage inducible transcript 3 (CHOP). J Clin Lab Anal.
34:e232522020. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Huang MS, Yuan FQ, Gao Y, Liu JY, Chen YX,
Wang CJ, He BM, Zhou HH and Liu ZQ: Circular RNA screening from
EIF3a in lung cancer. Cancer Med. 8:4159–4168. 2019. View Article : Google Scholar : PubMed/NCBI
|
